Transketolase-like protein 1 expression predicts poor prognosis in colorectal cancer

References

• Warburg O, Posener K, Negelein E. Über den Stoffwechsel der Carcinomzelle. Biochem Z 1924; 152:309-44; http://dx.doi.org/10.1007/BF01504608
   Google Scholar
• Wittig R, Coy JF. The role of glucose metabolism and glucose-associated signalling in cancer. Perspect Medicin Chem 2008; 1:64-82; PMID:19812737
   PubMedGoogle Scholar
• Xu X, Hausen Zur A, Coy JF, Löchelt M. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells. Int J Cancer 2009; 124:1330-7; PMID:19065656; http://dx.doi.org/10.1002/ijc.24078
   PubMed Web of Science ®Google Scholar
• Langbein S, Zerilli M, Hausen Zur A, Staiger W, Rensch-Boschert K, Lukan N, Popa J, Ternullo MP, Steidler A, Weiss C, et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br J Cancer 2006; 94:578-85; PMID:16465194; http://dx.doi.org/10.1038/sj.bjc.6602962
   PubMed Web of Science ®Google Scholar
• Schultz H, Kähler D, Branscheid D, Vollmer E, Zabel P, Goldmann T. TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens. Diagn Pathol 2008; 3:35; PMID:18700018; http://dx.doi.org/10.1186/1746-1596-3-35
   PubMed Web of Science ®Google Scholar
• Sun W, Liu Y, Glazer CA, Shao C, Bhan S, Demokan S, Zhao M, Rudek MA, Ha PK, Califano JA. TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization. Clin Cancer Res 2010; 16:857-66; PMID:20103683; http://dx.doi.org/10.1158/1078-0432.CCR-09-2604
   PubMed Web of Science ®Google Scholar
• Kayser G, Sienel W, Kubitz B, Mattern D, Stickeler E, Passlick B, Werner M, Hausen Zur A. Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression. Pathology 2011; 43:719-24; PMID:22027741; http://dx.doi.org/10.1097/PAT.0b013e32834c352b
   PubMed Web of Science ®Google Scholar
• Krockenberger M, Engel JB, Schmidt M, Kohrenhagen N, Häusler SFM, Dombrowski Y, Kapp M, Dietl J, Honig A. Expression of transketolase-like 1 protein (TKTL1) in human endometrial cancer. Anticancer Res 2010; 30:1653-9; PMID:20592357
   PubMed Web of Science ®Google Scholar
• Schmidt M, Voelker H-U, Kapp M, Krockenberger M, Dietl J, Kammerer U. Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK. J Cancer Res Clin Oncol 2010; 136:219-25; PMID:19655166; http://dx.doi.org/10.1007/s00432-009-0652-y
   PubMed Web of Science ®Google Scholar
• Chen H, Yue J-X, Yang S-H, Ding H, Zhao R-W, Zhang S. Overexpression of transketolase-like gene 1 is associated with cell proliferation in uterine cervix cancer. J Exp Clin Cancer Res 2009; 28:43; PMID:19331662; http://dx.doi.org/10.1186/1756-9966-28-43
   PubMed Web of Science ®Google Scholar
• Schwaab J, Horisberger K, Ströbel P, Bohn B, Gencer D, Kähler G, Kienle P, Post S, Wenz F, Hofmann W-K, et al. Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy. BMC Cancer 2011; 11:363; PMID:21854597; http://dx.doi.org/10.1186/1471-2407-11-363
   PubMed Web of Science ®Google Scholar
• Lange CA, Tisch-Rottensteiner J, Böhringer D, Martin G, Schwartzkopff J, Auw-Haedrich C. Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome. Ophthalmology 2012; 119:1924-9; PMID:22658715; http://dx.doi.org/10.1016/j.ophtha.2012.03.037
   PubMed Web of Science ®Google Scholar
• Grimm M, Hoefert S, Luz O, Reinert S, Polligkeit J. Transketolase-like protein 1 expression in recurrent oral squamous cell carcinoma after curative resection: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol 2013; 116:e173-8; PMID:22819458; http://dx.doi.org/10.1016/j.oooo.2011.12.022
   PubMed Web of Science ®Google Scholar
• Grimm M, Munz A, Teriete P, Nadtotschi T, Reinert S. GLUT-1(+)/TKTL1(+) coexpression predicts poor outcome in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2014; 117:743-53; PMID:24703406; http://dx.doi.org/10.1016/j.oooo.2014.02.007
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2014; 136:359–386; PMID:25220842
   PubMed Web of Science ®Google Scholar
• Böckelman C, Engelmann BE, Kaprio T, Hansen TF, Glimelius B. Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature. Acta Oncol 2015; 54:5-16; PMID:25430983; http://dx.doi.org/10.3109/0284186X.2014.975839
   PubMed Web of Science ®Google Scholar
• Hu L-H, Yang J-H, Zhang D-T, Zhang S, Wang L, Cai P-C, Zheng J-F, Huang J-S. The TKTL1 gene influences total transketolase activity and cell proliferation in human colon cancer LoVo cells. Anticancer Drugs 2007; 18:427-33; PMID:17351395; http://dx.doi.org/10.1097/CAD.0b013e328013d99e
   PubMed Web of Science ®Google Scholar
• Bentz S, Cee A, Endlicher E, Wojtal KA, Naami A, Pesch T, Lang S, Schubert P, Fried M, Weber A, et al. Hypoxia induces the expression of transketolase-like 1 in human colorectal cancer. Digestion 2013; 88:182-92; PMID:24193262; http://dx.doi.org/10.1159/000355015
   PubMed Web of Science ®Google Scholar
• Coy JF, Dressler D, Wilde J, Schubert P. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab 2005; 51:257-73; PMID:15991799
   PubMed Web of Science ®Google Scholar
• Diaz-Moralli S, Tarrado-Castellarnau M, Alenda C, Castells A, Cascante M. Transketolase-like 1 expression is modulated during colorectal cancer progression and metastasis formation. PLoS ONE 2011; 6:e25323; PMID:21980427; http://dx.doi.org/10.1371/journal.pone.0025323
   PubMedGoogle Scholar
• Rieger J, Bähr O, Maurer GD, Hattingen E, Franz K, Brucker D, Walenta S, Kammerer U, Coy JF, Weller M, et al. ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol 2014; 44:1843-52; PMID:24728273; http://dx.doi.org/10.3892/ijo.2014.2382
   PubMed Web of Science ®Google Scholar
• Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4:844-7; PMID:9662379; http://dx.doi.org/10.1038/nm0798-844
   PubMed Web of Science ®Google Scholar
• Nocito A, Kononen J, Kallioniemi OP, Sauter G. Tissue microarrays (TMAs) for high-throughput molecular pathology research. Int J Cancer 2001; 94:1-5; PMID:11668471; http://dx.doi.org/10.1002/ijc.1385
   PubMed Web of Science ®Google Scholar
• Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001; 10:657-62; PMID:11257096; http://dx.doi.org/10.1093/hmg/10.7.657
   PubMed Web of Science ®Google Scholar
• Torhorst J, Bucher C, Kononen J, Haas P, Zuber M, Köchli OR, Mross F, Dieterich H, Moch H, Mihatsch M, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001; 159:2249-56; PMID:11733374; http://dx.doi.org/10.1016/S0002-9440(10)63075-1
   PubMed Web of Science ®Google Scholar
• Böckelman C, Koskensalo S, Hagström J, Lundin M, Ristimäki A, Haglund C. CIP2A overexpression is associated with c-Myc expression in colorectal cancer. Cancer Biol Ther 2012; 13:289-95; PMID:22310977; http://dx.doi.org/10.4161/cbt.18922
   PubMed Web of Science ®Google Scholar